Cross-fund · 4 holders
CHRS
COHERUS ONCOLOGY INC
CUSIP 19249H103
4
Tracked holders
$32.9M
Aggregate value
21,098,999
Shares
4
Active funds
Funds holding CHRS
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| BlackRock | Institutional | Q1 2026 | $17.5M | — | -197,635 | -1.9% |
| Vanguard | Institutional | Q4 2025 | $14.2M | — | -292,214 | -2.8% |
| Citadel | Multi-Strategy | Q1 2026 | $664,248 | — | +239,946 | +156.7% |
| Millennium | Multi-Strategy | Q1 2026 | $527,256 | — | -348,465 | -52.8% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.